HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heart failure with preserved ejection fraction: insights into diagnosis and pathophysiology.

Abstract
Heart failure with preserved ejection fraction (HFpEF) accounts for at least half the cases of heart failure, currently diagnosed. There are several cardiac and non-cardiac manifestations of the syndrome. Structure and function abnormalities can include all four cardiac chambers. The left ventricle has abnormal systolic and diastolic functions which can be examined by invasive and non-invasive measurements. In addition, the left atrium enlarges with abnormal left atrial function, pulmonary hypertension occurs, and the right ventricle can develop hypertrophy, enlargement, and systolic dysfunction. There are a paucity of data on calcium handling in HFpEF patients. Growing literature supports the presence of abnormalities in titin and its phosphorylation, and increased interstitial fibrosis contributing to increased chamber stiffness. A systemic inflammatory state causing reduced myocardial cyclic guanosine monophosphate along with defects in the unfolded protein response have been recently reported. Diagnosis relies on signs and symptoms of heart failure, preserved ejection fraction, and detection of diastolic function abnormalities based on echocardiographic findings and abnormally elevated natriuretic peptide levels or invasive measurements of wedge pressure at rest or with exercise. There are currently two diagnostic algorithms: H2FPEF, and HFA-PEFF with limited data comparing their performance head to head in the same patient population. Despite the growing understanding of the syndrome's pathophysiology, there have been little success in developing specific treatment for patients with HFpEF.
AuthorsSherif F Nagueh
JournalCardiovascular research (Cardiovasc Res) Vol. 117 Issue 4 Pg. 999-1014 (03 21 2021) ISSN: 1755-3245 [Electronic] England
PMID32717061 (Publication Type: Journal Article, Review, Video-Audio Media)
CopyrightPublished on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: [email protected].
Topics
  • Animals
  • Cardiac Catheterization
  • Echocardiography
  • Exercise Test
  • Heart Failure, Diastolic (diagnosis, physiopathology, therapy)
  • Humans
  • Models, Cardiovascular
  • Predictive Value of Tests
  • Prognosis
  • Stroke Volume
  • Ventricular Dysfunction, Left (diagnosis, physiopathology, therapy)
  • Ventricular Function, Left
  • Ventricular Pressure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: